Progress in the Development of Alternative Pharmaceutical Formulations of Taxanes
- 1 May 2001
- journal article
- review article
- Published by Springer Nature in Investigational New Drugs
- Vol. 19 (2) , 143-153
- https://doi.org/10.1023/a:1010682916808
Abstract
The currently available taxanes paclitaxel(Taxol®) and docetaxel(Taxotere®) are clinically effectiveagainst advanced breast, ovarian andnon-small cell lung cancer. Due to theirlow aqueous solubility,...Keywords
This publication has 53 references indexed in Scilit:
- Hypersensitivity Reactions to the Taxanes Paclitaxel and DocetaxelClinical Drug Investigation, 1997
- Pharmaceutical Applications of Cyclodextrins. 1. Drug Solubilization and StabilizationJournal of Pharmaceutical Sciences, 1996
- Synthesis and evaluation of water-soluble polyethylene glycol-paclitaxel conjugate as a paclitaxel prodrugAnti-Cancer Drugs, 1996
- Pharmaceutical Development of (Investigational) Anticancer Agents for Parenteral Use-A ReviewDrug Development and Industrial Pharmacy, 1996
- Intratumoral chemotherapy with a sustained-release drug delivery system inhibits growth of human pancreatic cancer xenograftsAnti-Cancer Drugs, 1995
- Highly water soluble taxol derivatives: 2′-polyethyleneglycol esters as potential prodrugsBioorganic & Medicinal Chemistry Letters, 1994
- Structure-Activity Relationships of New Taxoids Derived from 14.beta.-Hydroxy-10-deacetylbaccatin IIIJournal of Medicinal Chemistry, 1994
- Cyclodextrins in the Pharmaceutical FieldDrug Development and Industrial Pharmacy, 1991
- Preparation and biological activity of taxol acetatesBiochemical and Biophysical Research Communications, 1984
- Histamine release in dogs by Cremophor El® and its derivatives: Oxethylated oleic acid is the most effective constituentInflammation Research, 1977